LifeMD LFMD 深 沪
等待开盘 11-04 09:30:00 美东时间
5.74
-0.170
-2.88%
华盛通- 最 高5.96
- 今 开5.96
- 成交量 73.45万股
- 最 低 5.69
- 昨 收 5.91
- 总市值 2.72亿
- 52周最高 15.84
- 市盈率 静 --
- 换手率 1.55%
- 52周最低 4.125
- 委 比 24.98%
- 总股本 4741.74万
- 历史最高 33.02
- 量 比 1.14
- 振 幅 4.57%
- 历史最低 1.14
- 每 手 1
- 风险率 2.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program
LifeMD appoints Tara Scott, MD, “The Hormone Guru,” as ambassador and clinical advisor for its comprehensive women’s health program. Dr. Scott, a renowned menopause and hormone specialist, will help elevate awareness and care for critical women’s health issues, including menopause, hormonal balance, and long-term wellness. LifeMD’s virtual program offers personalized therapies, virtual consultations, and holistic health strategies to address unde...
10-22 12:00
LFMD Lawsuit Alert! Class Action Lawsuit Against LifeMD
Aclass actionlawsuit was filed againstLifeMD ($LFMD) by Levi ...
10-10 20:59
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa., Oct. 9, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action law...
10-10 00:00
Novo Nordisk telling some employees accept demotion or lose job
Novo Nordisk (NVO), which is down ~36% year-to-date, is giving some employees a choice: Accept a demotion with lower pay or receive a pink slip. Some workers were given just 24 hours to proceed with a...
09-30 22:10
LifeMD Expands Novo Nordisk Collaboration To Offer Ozempic Access At $499/Month
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patientsNEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today
09-30 20:12
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
LifeMD has announced a collaboration with Novo Nordisk to offer Ozempic<sup>®</sup> (semaglutide) at $499 per month for eligible self-pay and uninsured patients, including those whose insurance doesn’t cover GLP-1 therapies. The telehealth platform integrates with NovoCare<sup>®</sup> Pharmacy, providing access to all FDA-approved dose strengths of Ozempic<sup>®</sup> and Wegovy<sup>®</sup>, along with virtual consultations, clinical support, dia...
09-30 12:00
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend
LifeMD, Inc. 8.875% CUM PFD A (NASDAQ:LFMDP) declares $0.5547/share quarterly dividend. Forward yield 9.25% Payable Oct. 15; for shareholders of record Oct. 3; ex-div Oct. 3. See LFMDP Dividend Scorec...
09-24 04:11
LifeMD Expands Affiliated Pharmacy To Include Advanced Non-Sterile Compounding Capabilities For Oral And Topical Medications
LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the expansion of its state-of-the-art affiliated pharmacy to include advanced non-sterile compounding capabilities for oral
09-18 20:12
LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale
<p>LifeMD, Inc. announced the expansion of its affiliated pharmacy to include advanced non-sterile compounding capabilities for oral and topical medications. This enhancement supports specialized therapies, improves patient convenience, and increases operational efficiency. The pharmacy can now formulate customized medications, including allergen-free and combination products not commercially available. LifeMD’s strategic expansion aligns with it...
09-18 12:00
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its ex...
09-10 06:24
